{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:10:50Z","timestamp":1759057850702},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Innate lymphoid cells (ILC) are lymphoid lineage innate immune cells that do not mount antigen-specific responses due to their lack of B and T-cell receptors. ILCs are predominantly found at mucosal surfaces, as gatekeepers against invading infectious agents through rapid secretion of immune regulatory cytokines. HIV associated destruction of mucosal lymphoid tissue depletes ILCs, among other immune dysfunctions. Studies have described limited restoration of ILCs during the first three years of combined antiretroviral therapy (cART). Little is known about restoration of ILCs during long-term cART, particularly in sub-Saharan Africa which hosts increasing numbers of adults with at least a decade of cART.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We examined phenotypes and function of ILCs from peripheral blood mononuclear cells after 12\u00a0years of suppressive cART. We report that ILC1 frequencies (T-BET\u2009+\u2009CD127\u2009+\u2009and CD161\u2009+) were higher in cART-treated HIV-infected relative to age-matched health HIV-negative adults; P\u2009=\u20090.04 whereas ILC precursors (ILCP) were comparable in the two groups (P\u2009=\u20090.56). Interferon gamma (IFN-\u03b3) secretion by ILC1 was higher among cART-treated HIV-infected relative to HIV-negative adults (P\u2009=\u20090.03).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>HIV associated alteration of ILC persisted during cART and may likely affect the quality of host innate and adaptive immune responses during long-term cART.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12865-021-00450-8","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T10:03:55Z","timestamp":1629972235000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Innate lymphoid cell dysfunction during long-term suppressive antiretroviral therapy in an African cohort"],"prefix":"10.1186","volume":"22","author":[{"given":"Rose","family":"Nabatanzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois","family":"Bayigga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Cose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda","family":"Canderan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Rowland Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses","family":"Joloba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damalie","family":"Nakanjako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"issue":"2","key":"450_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nri3349","volume":"13","author":"JA Walker","year":"2013","unstructured":"Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells\u2014how did we miss them? Nat Rev Immunol. 2013;13(2):75\u201387.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"450_CR2","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1182\/blood-2013-11-427781","volume":"124","author":"MD Hazenberg","year":"2014","unstructured":"Hazenberg MD, Spits H. Human innate lymphoid cells. Blood. 2014;124(5):700\u20139.","journal-title":"Blood"},{"issue":"6237","key":"450_CR3","doi-asserted-by":"publisher","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","volume":"348","author":"G Eberl","year":"2015","unstructured":"Eberl G, Colonna M, Di Santo JP, McKenzie AN. Innate lymphoid cells: A new paradigm in immunology. Science. 2015;348(6237):aaa6566.","journal-title":"Science"},{"key":"450_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.imlet.2016.07.005","volume":"179","author":"VS Cortez","year":"2016","unstructured":"Cortez VS, Colonna M. Diversity and function of group 1 innate lymphoid cells. Immunol Lett. 2016;179:19\u201324.","journal-title":"Immunol Lett"},{"key":"450_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/82_2015_474","volume-title":"Natural killer cells","author":"C Seillet","year":"2015","unstructured":"Seillet C, Belz GT, Huntington ND. Development, homeostasis, and heterogeneity of NK cells and ILC1. In: Vivier E, Di Santo J, Moretta A, editors. Natural killer cells. Berlin: Springer; 2015. p. 37\u201361."},{"issue":"2","key":"450_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells\u2014a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2):145\u20139.","journal-title":"Nat Rev Immunol"},{"issue":"7280","key":"450_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature08636","volume":"463","author":"K Moro","year":"2010","unstructured":"Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, et al. Innate production of T H 2 cytokines by adipose tissue-associated c-Kit+ Sca-1+ lymphoid cells. Nature. 2010;463(7280):540.","journal-title":"Nature"},{"issue":"3","key":"450_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.immuni.2014.01.012","volume":"40","author":"R Yagi","year":"2014","unstructured":"Yagi R, Zhong C, Northrup DL, Yu F, Bouladoux N, Spencer S, et al. The transcription factor GATA3 is critical for the development of all IL-7R\u03b1-expressing innate lymphoid cells. Immunity. 2014;40(3):378\u201388.","journal-title":"Immunity"},{"issue":"1","key":"450_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ni.1962","volume":"12","author":"H Spits","year":"2011","unstructured":"Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2011;12(1):21.","journal-title":"Nat Immunol"},{"issue":"1","key":"450_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.it.2015.11.003","volume":"37","author":"CH Kim","year":"2016","unstructured":"Kim CH, Hashimoto-Hill S, Kim M. Migration and tissue tropism of innate lymphoid cells. Trends Immunol. 2016;37(1):68\u201379.","journal-title":"Trends Immunol"},{"issue":"7","key":"450_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nm.3892","volume":"21","author":"GF Sonnenberg","year":"2015","unstructured":"Sonnenberg GF, Artis D. Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med. 2015;21(7):698.","journal-title":"Nat Med"},{"issue":"3","key":"450_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.immuni.2014.09.006","volume":"41","author":"AN McKenzie","year":"2014","unstructured":"McKenzie AN, Spits H, Eberl G. Innate lymphoid cells in inflammation and immunity. Immunity. 2014;41(3):366\u201374.","journal-title":"Immunity"},{"issue":"4","key":"450_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","volume":"38","author":"A Fuchs","year":"2013","unstructured":"Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-and IL-15-responsive IFN-\u03b3-producing cells. Immunity. 2013;38(4):769\u201381.","journal-title":"Immunity"},{"issue":"2","key":"450_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/rr40","volume":"2","author":"JW Steinke","year":"2001","unstructured":"Steinke JW, Borish L. Th2 cytokines and asthma\u2014Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res. 2001;2(2):66.","journal-title":"Respir Res"},{"issue":"7293","key":"450_CR15","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nature08900","volume":"464","author":"DR Neill","year":"2010","unstructured":"Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464(7293):1367.","journal-title":"Nature"},{"key":"450_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41586-019-1276-2","volume":"570","author":"A Ardain","year":"2019","unstructured":"Ardain A. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019;570:528\u201332.","journal-title":"Nature"},{"issue":"1","key":"450_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1600-065X.2011.01071.x","volume":"245","author":"G Eberl","year":"2012","unstructured":"Eberl G. Development and evolution of ROR\u03b3t+ cells in a microbe\u2019s world. Immunol Rev. 2012;245(1):177\u201388.","journal-title":"Immunol Rev"},{"issue":"2","key":"450_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.immuni.2014.07.006","volume":"41","author":"RM Maizels","year":"2014","unstructured":"Maizels RM, Withers DR. MHC-II: a mutual support system for ILCs and T cells? Immunity. 2014;41(2):174\u20136.","journal-title":"Immunity"},{"issue":"7452","key":"450_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature12240","volume":"498","author":"MR Hepworth","year":"2013","unstructured":"Hepworth MR, Monticelli LA, Fung TC, Ziegler CG, Grunberg S, Sinha R, et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature. 2013;498(7452):113.","journal-title":"Nature"},{"issue":"18","key":"450_CR20","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1097\/QAD.0000000000001289","volume":"30","author":"SM Dillon","year":"2016","unstructured":"Dillon SM, Frank DN, Wilson CC. The gut microbiome and HIV-1 pathogenesis: a two way street. AIDS. 2016;30(18):2737.","journal-title":"AIDS"},{"issue":"12","key":"450_CR21","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365\u201371.","journal-title":"Nat Med"},{"key":"450_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11904-019-00439-4","volume":"16","author":"JC Mudd","year":"2019","unstructured":"Mudd JC, Brenchley JM. Innate lymphoid cells: their contributions to gastrointestinal tissue homeostasis and HIV\/SIV disease pathology. Curr HIV\/AIDS Rep. 2019;16:181\u201390.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"S1","key":"450_CR23","doi-asserted-by":"publisher","first-page":"A14","DOI":"10.1089\/aid.2014.5015.abstract","volume":"30","author":"HN Kl\u00f8verpris","year":"2014","unstructured":"Kl\u00f8verpris HN, Noorbhai A, Kuhn W, Yadon M, Ramsuran D, Nhamoyebonde S, et al. Innate lymphoid cells are depleted in HIV infection. AIDS Res Hum Retroviruses. 2014;30(S1):A14.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"450_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.immuni.2016.01.006","volume":"44","author":"HN Kl\u00f8verpris","year":"2016","unstructured":"Kl\u00f8verpris HN, Kazer SW, Mj\u00f6sberg J, Mabuka JM, Wellmann A, Ndhlovu Z, et al. Innate lymphoid cells are depleted irreversibly during acute HIV-1 infection in the absence of viral suppression. Immunity. 2016;44(2):391\u2013405.","journal-title":"Immunity"},{"key":"450_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clim.2019.02.010","volume":"201","author":"R Nabatanzi","year":"2019","unstructured":"Nabatanzi R, Bayigga L, Cose S, Rowland-Jones S, Canderan G, Joloba M, et al. Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort. Clin Immunol. 2019;201:55\u201360. https:\/\/doi.org\/10.1016\/j.clim.2019.02.010.","journal-title":"Clin Immunol"},{"issue":"2 Pt B","key":"450_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.imlet.2014.09.016","volume":"162","author":"R Nabatanzi","year":"2014","unstructured":"Nabatanzi R, Bayigga L, Ssinabulya I, Kiragga A, Kambugu A, Olobo J, et al. Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort. Immunol Lett. 2014;162(2 Pt B):264\u201372. https:\/\/doi.org\/10.1016\/j.imlet.2014.09.016.","journal-title":"Immunol Lett"},{"issue":"1","key":"450_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12981-018-0194-y","volume":"15","author":"R Nabatanzi","year":"2018","unstructured":"Nabatanzi R, Cose S, Joloba M, Jones SR, Nakanjako D. Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells. AIDS Res Ther. 2018;15(1):7. https:\/\/doi.org\/10.1186\/s12981-018-0194-y.","journal-title":"AIDS Res Ther"},{"issue":"2","key":"450_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.immuni.2016.01.006","volume":"44","author":"HN Kloverpris","year":"2016","unstructured":"Kloverpris HN, Kazer SW, Mjosberg J, Mabuka JM, Wellmann A, Ndhlovu Z, et al. Innate lymphoid cells are depleted irreversibly during acute HIV-1 infection in the absence of viral suppression. Immunity. 2016;44(2):391\u2013405. https:\/\/doi.org\/10.1016\/j.immuni.2016.01.006.","journal-title":"Immunity"},{"issue":"1","key":"450_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/mi.2015.58","volume":"9","author":"K Allers","year":"2016","unstructured":"Allers K, Puyskens A, Epple HJ, Schurmann D, Hofmann J, Moos V, et al. The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients. Mucosal Immunol. 2016;9(1):265\u201374. https:\/\/doi.org\/10.1038\/mi.2015.58.","journal-title":"Mucosal Immunol"},{"issue":"18","key":"450_CR30","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1001\/archinte.163.18.2187","volume":"163","author":"GR Kaufmann","year":"2003","unstructured":"Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med. 2003;163(18):2187\u201395. https:\/\/doi.org\/10.1001\/archinte.163.18.2187.","journal-title":"Arch Intern Med"},{"issue":"4","key":"450_CR31","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1086\/338929","volume":"185","author":"V Le Moing","year":"2002","unstructured":"Le Moing V, Thiebaut R, Chene G, Leport C, Cailleton V, Michelet C, et al. Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen. J Infect Dis. 2002;185(4):471\u201380. https:\/\/doi.org\/10.1086\/338929.","journal-title":"J Infect Dis"},{"issue":"2","key":"450_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.imlet.2014.09.016","volume":"162","author":"R Nabatanzi","year":"2014","unstructured":"Nabatanzi R, Bayigga L, Ssinabulya I, Kiragga A, Kambugu A, Olobo J, et al. Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort. Immunol Lett. 2014;162(2):264\u201372.","journal-title":"Immunol Lett"},{"key":"450_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2014.09.016","author":"R Nabatanzi","year":"2014","unstructured":"Nabatanzi R, Bayigga L, Ssinabulya I, Kiragga A, Kambugu A, Olobo J, et al. Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort. Immunol Lett. 2014. https:\/\/doi.org\/10.1016\/j.imlet.2014.09.016.","journal-title":"Immunol Lett"},{"issue":"6","key":"450_CR34","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.cell.2017.02.021","volume":"168","author":"AI Lim","year":"2017","unstructured":"Lim AI, Li Y, Lopez-Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell. 2017;168(6):1086\u2013100. https:\/\/doi.org\/10.1016\/j.cell.2017.02.021.","journal-title":"Cell"},{"key":"450_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fimmu.2016.00104","volume":"7","author":"A Fuchs","year":"2016","unstructured":"Fuchs A. ILC1s in tissue inflammation and infection. Front Immunol. 2016;7:104. https:\/\/doi.org\/10.3389\/fimmu.2016.00104.","journal-title":"Front Immunol"},{"issue":"4","key":"450_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ni.2002","volume":"12","author":"S Sawa","year":"2011","unstructured":"Sawa S, Lochner M, Satoh-Takayama N, Dulauroy S, B\u00e9rard M, Kleinschek M, et al. ROR\u03b3t+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol. 2011;12(4):320.","journal-title":"Nat Immunol"},{"key":"450_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0282-9","author":"SM Bal","year":"2020","unstructured":"Bal SM, Golebski K, Spits H. Plasticity of innate lymphoid cell subsets. Nat Rev Immunol. 2020. https:\/\/doi.org\/10.1038\/s41577-020-0282-9.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"450_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","volume":"43","author":"JH Bernink","year":"2015","unstructured":"Bernink JH, Krabbendam L, Germar K, de Jong E, Gronke K, Kofoed-Nielsen M, et al. Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity. 2015;43(1):146\u201360. https:\/\/doi.org\/10.1016\/j.immuni.2015.06.019.","journal-title":"Immunity"},{"issue":"3","key":"450_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni.2534","volume":"14","author":"JH Bernink","year":"2013","unstructured":"Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol. 2013;14(3):221\u20139. https:\/\/doi.org\/10.1038\/ni.2534.","journal-title":"Nat Immunol"},{"key":"450_CR40","doi-asserted-by":"publisher","unstructured":"Wang Y, Gellatly K, Derr A, Jaiswal S, Kucukural A, McDonel P et al. HIV-1 unmasks the plasticity of innate lymphoid cells. bioRxiv. 2018:221010. doi:https:\/\/doi.org\/10.1101\/221010.","DOI":"10.1101\/221010"},{"key":"450_CR41","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. https:\/\/doi.org\/10.3389\/fimmu.2018.00754.","journal-title":"Front Immunol"},{"key":"450_CR42","first-page":"1","volume":"12","author":"S Mehandru","year":"2007","unstructured":"Mehandru S. The gastrointestinal tract in HIV-1 infection: questions, answers, and more questions. PRN Noteb. 2007;12:1\u201310.","journal-title":"PRN Noteb"},{"issue":"6","key":"450_CR43","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/mi.2012.38","volume":"5","author":"NR Klatt","year":"2012","unstructured":"Klatt NR, Estes JD, Sun X, Ortiz AM, Barber JS, Harris LD, et al. Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 2012;5(6):646.","journal-title":"Mucosal Immunol"},{"issue":"12","key":"450_CR44","doi-asserted-by":"publisher","first-page":"e1004551","DOI":"10.1371\/journal.ppat.1004551","volume":"10","author":"H Li","year":"2014","unstructured":"Li H, Richert-Spuhler LE, Evans TI, Gillis J, Connole M, Estes JD, et al. Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection. PLoS Pathog. 2014;10(12):e1004551.","journal-title":"PLoS Pathog"},{"key":"450_CR45","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","volume":"43","author":"JH Bernink","year":"2015","unstructured":"Bernink JH, Krabbendam L, Germar K, de Jong E, Gronke K, Kofoed-Nielsen M, Munneke JM, Hazenberg MD, Villaudy J, Buskens CJ, Bemelman WA, Diefenbach A, Blom B, Spits H. Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity. 2015;43:146\u201360.","journal-title":"Immunity"},{"key":"450_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:1. https:\/\/doi.org\/10.3389\/fimmu.2018.00754.","journal-title":"Front Immunol"},{"issue":"4","key":"450_CR47","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jcv.2009.09.011","volume":"46","author":"S Baroncelli","year":"2009","unstructured":"Baroncelli S, Galluzzo CM, Pirillo MF, Mancini MG, Weimer LE, Andreotti M, et al. Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies\/ml HIV-1 RNA. J Clin Virol. 2009;46(4):367\u201370.","journal-title":"J Clin Virol"},{"issue":"16","key":"450_CR48","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1097\/01.aids.0000188426.87538.ed","volume":"19","author":"L Palmisano","year":"2005","unstructured":"Palmisano L, Giuliano M, Nicastri E, Pirillo MF, Andreotti M, Galluzzo CM, et al. Residual viraemia in subjects with chronic HIV infection and viral load< 50 copies\/ml: the impact of highly active antiretroviral therapy. AIDS. 2005;19(16):1843\u20137.","journal-title":"AIDS"},{"key":"450_CR49","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/infdis\/jiz320","volume":"220","author":"R Nabatanzi","year":"2019","unstructured":"Nabatanzi R, Bayigga L, Cose S, Rowland Jones S, Joloba M, Canderan G, et al. Monocyte dysfunction, activation and inflammation after long-term antiretroviral therapy in an African cohort. J Infect Dis. 2019;220:1414\u20139.","journal-title":"J Infect Dis"},{"issue":"5","key":"450_CR50","doi-asserted-by":"publisher","first-page":"e1006373","DOI":"10.1371\/journal.ppat.1006373","volume":"13","author":"B Kr\u00e4mer","year":"2017","unstructured":"Kr\u00e4mer B, Goeser F, Lutz P, Gl\u00e4ssner A, Boesecke C, Schwarze-Zander C, et al. Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy. PLoS Pathog. 2017;13(5):e1006373.","journal-title":"PLoS Pathog"},{"issue":"7436","key":"450_CR51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nature11813","volume":"494","author":"CS Klose","year":"2013","unstructured":"Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d\u2019Hargues Y, et al. A T-bet gradient controls the fate and function of CCR6\u2212 ROR\u03b3t+ innate lymphoid cells. Nature. 2013;494(7436):261.","journal-title":"Nature"},{"issue":"5","key":"450_CR52","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5):503\u201310.","journal-title":"Nat Immunol"},{"issue":"2","key":"450_CR53","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","volume":"157","author":"CS Klose","year":"2014","unstructured":"Klose CS, Flach M, M\u00f6hle L, Rogell L, Hoyler T, Ebert K, et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell. 2014;157(2):340\u201356.","journal-title":"Cell"},{"issue":"14","key":"450_CR54","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1038\/emboj.2011.201","volume":"30","author":"A Reynders","year":"2011","unstructured":"Reynders A, Yessaad N, Manh TPV, Dalod M, Fenis A, Aubry C, et al. Identity, regulation and in vivo function of gut NKp46+ ROR\u03b3t+ and NKp46+ ROR\u03b3t\u2212 lymphoid cells. EMBO J. 2011;30(14):2934\u201347.","journal-title":"EMBO J"},{"issue":"2","key":"450_CR55","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","volume":"25","author":"L R\u00f6nnblom","year":"2013","unstructured":"R\u00f6nnblom L, Eloranta M-L. The interferon signature in autoimmune diseases. Curr Opin Rheumatol. 2013;25(2):248\u201353.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"450_CR56","first-page":"29","volume":"11","author":"ES Lugada","year":"2004","unstructured":"Lugada ES, Mermin J, Kaharuza F, Ulvestad E, Were W, Langeland N, et al. Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol. 2004;11(1):29\u201334.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"450_CR57","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Th\u00e9r\u00e9sine M, Andr\u00e8s E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology. 2009;126(4):458\u201365. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.03027.x.","journal-title":"Immunology"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-021-00450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-021-00450-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-021-00450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T10:11:01Z","timestamp":1629972661000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-021-00450-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["450"],"URL":"https:\/\/doi.org\/10.1186\/s12865-021-00450-8","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"27 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was sought from the School of Biomedical Sciences Makerere University College of Health Sciences Research and Ethics Committee. All participants provided written informed consent for storage and future use of their samples in studies to understand host immune recovery during cART. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they do not have any competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}